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Abstract: The Centre for Human Drug Research (CHDR) is a non-profit clinical research institute at the interface between acade-
mia and the pharmaceutical industry. CHDR hosts a research internship programme for undergraduate (bio)medical students. The
aim of this study was (i) to investigate the student perceptions of the undergraduate research internship and (ii) to quantify the
scientific output related to these internships. We surveyed former interns at the CHDR from the year 2007 to 2014 and quantified
their scientific output with a PubMed search. There was a response rate to the survey of 61%, with a good overall rating of the
internships. Many students considered their internship at CHDR to be (much) more broad (55%) and with a (much) stricter plan-
ning (48%), compared to previous internships at academic research groups. In turn, there were many aspects reported to be simi-
lar to academic research internships such as focus on research methodology and ‘outcome-drivenness’. Twenty-four per cent of
the internships resulted in a co-authorship on papers published in peer-reviewed journals with an average impact factor of 3.3. In
conclusion, with appropriate management and supervision, effective research electives are possible in the more commercial envi-
ronment of a clinical research organization.
Academic healthcare education has always struggled to find a
balance between clinical and scientific education. It is the science
component that is often short-changed in academic curricula:
although most (75%) European medical schools offer research
courses during the undergraduate curricula, there is still room for
improvement of the science component in many schools [1].
This contrasts with the importance of skills developed during
science and research education [2]. Science and research educa-
tion teaches students how to critically assess scientific literature
and familiarizes them with emerging areas of biomedical science
and pharmaceutical science [3]. These skills are crucial to prac-
ticing evidence-based medicine later in their career [4].
But even for students with a more research-focused curricu-
lum (e.g. biomedical sciences, biopharmaceutical sciences),
there is no substitute for the experience gained during a
research internship. The execution of an independent research
project has been described as ‘probably the most authentic way
to develop research skills’ [4,5]. Studies report that undergradu-
ate research projects increase science career decisions, active
learning and the ability to ‘think like a scientist’ [6,7].
The Centre for Human Drug Research (CHDR) is a non-
profit clinical research organization with legal status of a foun-
dation which focuses on biomarker development and data-
intensive, early-phase pharmacokinetics and pharmacodynam-
ics clinical trials in most therapeutic areas. At CHDR, an
undergraduate research internship programme has been
running since CHDR’s inception in 1987. CHDR has strong
ties with the nearby Leiden University, with many of its senior
staff holding faculty positions. However, the context in which
the research internship is performed differs in several ways
between a CHDR internship and an internship at an academic
research group. One difference is the nature of research, which
is more applied clinical research, as opposed to basic research
at academia. Furthermore, the studies are often funded by the
pharmaceutical industry which is also reflected in the more com-
mercial organizational structure of CHDR. Revenue from these
sponsored studies are used to fund investigator-initiated clinical
studies, biomarker and method development, education of staff
and students at Leiden University and Leiden University Medi-
cal Center, and CHDR’s undergraduate internship programme.
The CHDR undergraduate internship programme primarily
aims to convey knowledge, skills and experience in human
drug development while giving students the opportunity to
experience the scientific methods first-hand. In a typical year,
60–70 applicants will compete for up to 20 student internship
positions. Students may apply from any country or training
background as long as they can demonstrate: (i) being a self-
directed learner; (ii) having a strong command of the English
language; and (iii) possessing a reasonable familiarity with the
research process. Once accepted, students are paired with a
supervisor who is responsible for assessing the student’s per-
formance and level of completion of both the student’s indi-
vidual scientific and CHDR’s internal training plans. The
scientific training plan and requirements for successful com-
pletion of the internship are generally dictated by the student’s
course programme, so that they obtain study credit points for
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the internship. The intern is also provided with a trainer
responsible for day-to-day guidance during the internship. The
focus of the internship is the student’s involvement in a speci-
fic research project at the CHDR (e.g. a part of clinical study
or PK-PD modelling analysis). Interns are expected to partici-
pate in weekly educational sessions which include clinical
pharmacology lectures and journal clubs. They also attend
monthly scientific discussions where planned and completed
trials are critically discussed. This exposes the students to the
CHDR research community and makes them familiar with
practical issues surrounding research, two factors that have
been suggested to promote student engagement in academic
medicine [8]. The research internships are concluded with an
oral presentation and a written report that ideally leads to pre-
sentation at (inter)national conferences and publication in a
peer-reviewed journal. After graduation, former interns occa-
sionally return to CHDR to continue their education as a PhD
candidate and CHDR project leader. An example internship
project and curriculum vitae is given for illustration purposes
(Supporting information).
This study aimed to evaluate the views of former interns
regarding the CHDR internship programme with a question-
naire. The questionnaire included some general questions on
the intern’s satisfaction with certain elements of the internship
programme. Other questions focused on the context of a
research internship at CHDR, and asked students to compare
their experiences at CHDR with previous internships at aca-
demic research groups. In addition to the questionnaire, we
assessed the scientific output of the programme by identifying
co-authorships by former interns on publications or manu-
scripts directly related to their internship at CHDR.
Material and Methods
Survey. An anonymous 32-item questionnaire was created using
Google Forms (Google Inc., Mountain View, CA, USA) and
validated by two CHDR employees. Eighty-seven students that started
their internship at CHDR in the years 2007–2014 were identified and
invited by email to participate in the survey. One week after the
initial invitation, a reminder was sent by email to all non-responders.
The first part of the questionnaire consisted of questions regarding
demographic data including starting year, internship duration and
education phase during the internship. Six questions evaluated the
students’ attitudes towards the quality of the supervision, scientific
value and commercial influence by means of Likert statements while
an additional three questions assessed perception of their own
performance, their own knowledge of clinical research methodologies
and overall satisfaction with the internship. Students were asked to
compare their internship at CHDR internships with internships at
academic research groups. Lastly, open-ended questions were offered
to query strengths and weaknesses and inviting any additional
comments or suggestions. The questionnaire was composed of
multiple-choice questions, multiple-answer questions and 4- or 5-point
Likert-type scales. All survey participants answered voluntarily and
none of the questions was marked mandatory to enable students to
answer freely.
Under the Netherlands Law for Research on Human Subjects
(WMO), this study was considered as an observational study in which
the subjects are not submitted to risks or special requirements other
than a short questionnaire. Additionally, the objectives of the study
were not medical research but rather educational research. Because of
this, ethical clearance in the Netherlands is unnecessary and the study
was therefore only reviewed by the scientific advisory board of our
institution. The consent to participate was obtained from each individ-
ual prior to answering the survey.
Analysis. Survey responses were automatically collected in a Google
Docs spreadsheet. Data analysis and visualization was performed
with R version 3.1.2 with R packages ‘vcdExtra’ 0.6-5 and ‘likert’
1.2.1 [9–11]. Answers to the open-ended questions were screened to
identify common themes. The Wilcoxon rank-sum test was used for
statistical comparison of internships performed during Master phase or
pre-master phase of the intern’s study. The Goodman–Kruskal gamma
was calculated to test for significant correlation between answers to
different questions, where appropriate.
The questions regarding the comparison of the context of academic
and CHDR internships focus on (bio)medical research internships. We
therefore excluded answers to these questions if: (i) the CHDR intern-
ship focused exclusively on business/management (ii) the respondents
were not believed to have participated in a research internship at an
academic group previously. Examples of ‘b’ include students who per-
formed a CHDR internship during the pre-master phase or students
with a business/management background. After these exclusions,
answers from 32 respondents were left for the analysis of the ‘compar-
ison of context’ questions.
Scientific output. A PubMed search was performed on 6 January
2015 to identify publications with contributions from (former) CHDR
interns (in the period of 2007–2014) with CHDR affiliation. Hits were
confirmed by abstract reading and verification of correctness with
senior staff. All manuscripts currently in preparation or in the
submission process were derived from senior staff of CHDR in
January 2015. Journal impact factors were obtained from the Journal
Citation Reports 2013 [12].
Results
Demographics.
A total of 87 students started an internship at CHDR in the
period of 2007–2014, and 53 (61%) of them consented and
responded to the survey. Three students could not be con-
tacted due to expired contact details, and the remainder did
not respond to the survey invitations. Demographics of the
survey respondents are shown in table 1. Student interns have
various backgrounds including biopharmaceutical sciences
(45.3%), biomedical sciences (17.0%), medicine (17.0%) and
pharmacy (9%). Most of the students performed their intern-
ship during the Master phase of their study (73.6%). The most
common nationality of the respondents was Dutch (73.6%)
with the remainder coming from other countries across the
world, such as Mexico, USA and Japan. The most common
internship durations were 21–27 weeks (26.4%) and
≥36 weeks (28.3%). The area of research of the respondents’
internships is summarized in fig. 1. Students were allowed to
choose multiple keywords to describe the scope of their
internship research. The most commonly selected keywords
were Central Nervous System (CNS) (45.3%), Clinical Phar-
macology (43.4%) and PK-PD modelling (37.7%), which
match important areas of research at CHDR. Only five
students (9.4%) indicated that their internship entailed (any)
business/management components.
© 2017 The Authors. Basic & Clinical Pharmacology & Toxicology published by John Wiley & Sons Ltd on behalf of Nordic Association for the Publication of BCPT
(former Nordic Pharmacological Society)
CLINICAL PHARMACOLOGY RESEARCH INTERNSHIPS 23
Open-ended questions.
We identified several common (>10% occurrence) themes in
the open-ended questions on the strengths and weaknesses of
the CHDR internship programme. Respondents appreciated
that they were able to experience clinical drug development
(44%) in a commercial setting (19%) and also mentioned
interdisciplinary collaboration as one of the strengths of the
CHDR internship programme (26%). While some students
(19%) reported that they would have benefited from additional
guidance from their supervisor, others (19%) appreciated the
level of responsibility and independence that they were given
as an intern. Sometimes, the clinical trial that was the subject
of the intern’s research was postponed or cancelled. Although
these situations were often outside of CHDR’s control, they
would sometimes require that intern to focus on a different
research topic. This uncertainty was mentioned by several stu-
dents (17%) as a weakness of the internship programme.
Likert statements on general internship quality.
Students were asked to evaluate five positive and one negative
statements regarding their internship using a 4-point Likert-
type scale ranging from Strongly Disagree – 1 to Strongly
Agree – 4 (fig. 2). 80.5% of the respondents strongly agreed
that the internship was helpful to their career. Most of the stu-
dents (strongly) agreed with other positive statements regard-
ing the scientific value of the research project, and the quality
of supervision: 97.8% and 91.8%, respectively. Most students
(78.5%) reported having been able to complete their research
project during their internship and generally (84.8%) agreed
that their project’s research question was clearly stated. In
contrast, all but one student (strongly) disagreed with the
negative statement regarding the distraction caused by the
commercial setting of CHDR.
Likert-type scale self-assessment and internship perception.
As part of this survey, students rated their own knowledge and
performance, and several aspects of the internship using a 5-
point Likert-type scale ranging from Poor – 1 to Excellent – 5
(fig. 3). Respondents were confident about their own perfor-
mance and knowledge of (clinical) research, with over 90% of
them scoring Average – 3 or higher. Both the educational pro-
gramme of CHDR and the overall rating of the internship
scored high; the percentages of students rating these aspects as
either Good – 4 or Excellent – 5 were 86.8% and 84.9%,
respectively. In addition, none of the respondents scored the
overall rating of the internship below Average – 3. This
resulted in an average score of 4.26 out of 5. Some students
(18.9%) reported either a Poor – 1 or Moderate – 2 link
between their internship project and their prior knowledge.
Interestingly, respondents who performed their internship dur-
ing the pre-master phase of their study scored significantly
lower on this aspect than those who did during the Master
phase (p < 0.01). We observed the same trend in the students’
score on ‘Own knowledge of (clinical) research’ (p < 0.01).
This parameter was also positively correlated to the duration of
the internship (Goodman–Kruskal gamma = 0.37, p < 0.05).
Comparison of context with previous (academic) internships.
One part of the survey was explicitly dedicated to the compar-
ison between the CHDR research internship and previous
internships – typically performed at an academic research
Table 1.





The Netherlands 39 (73.6)
Other European countries 3 (5.7)
The Americas 5 (9.4)
Other countries 4 (7.5)
No response 2 (3.8)
Background
Bio-Pharmaceutical Sciences 24 (45.3)
Medicine 9 (17.0)
Bio medical Sciences 9 (17.0)
Pharmacy 5 (9.4)
Other 7 (13.2)





≤6 weeks 2 (3.8)
7–14 weeks 7 (13.2)
15–20 weeks 5 (9.4)
21–27 weeks 14 (26.4)
28–35 weeks 10 (18.9)
≥36 weeks 15 (28.3)
Fig. 1. Scope of internships 2007–2014 as reported by elective stu-
dents. Respondents were allowed to select multiple keywords for the
description. Only keywords selected by at least five respondents are
shown.
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group at a university or academic hospital. Students were
asked to rate several aspects on a 5-point Likert-type scale
ranging from Much less – 1 to Much more – 5. The strongest
trends in respondent answers were that CHDR internships
were characterized as having a (much) broader scope (55%)
and (much) stricter planning (48%) (fig. 4). Although the
majority of the students scored Same – 3 on focus on research
methodology (63%) and outcome-drivenness (55%), there was
a trend towards More/Much more on these aspects. The strict-
ness of supervision and education, and the level of hands-on
research experience are comparable to that experienced by
students in previous internships, with no clear trends.
Fig. 2. Heat map of Likert statements evaluating the internship in general and self-assessment. The colour corresponds to the percentage of respon-
dents who selected that option for a particular statement. Mean and standard deviation (S.D.) are given to aid interpretation: strongly disagree – 1;
disagree – 2; agree – 3; strongly agree – 4.
Fig. 3. Heat map of Likert-type scale outcome of context based questions and comparison to academic internships. The colour corresponds to the
percentage of respondents who selected that option for a particular question. Mean and standard deviation (S.D.) are given to aid interpretation:
poor – 1; moderate – 2; average – 3; good – 4; excellent – 5.
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Scientific output.
A total of 21 CHDR interns of 2007–2014 (24%) are listed
co-authors on 23 papers that are related to their internships.
These papers were published in peer-reviewed journals with
an average impact factor of 3.3 (1.9). Furthermore, interns
contributed to three recently submitted manuscripts and seven
manuscripts with students in the author list are currently in
preparation, adding up to a total of 33 manuscripts. In total,
28 interns (32%) were at some point involved in the writing
of a manuscript related to their internship.
Discussion
Scientific training is an important pillar of education of (bio)
medical students [1]. CHDR provides a unique environment for
this: a non-profit clinical research organization at the interface
between academia and the pharmaceutical industry. We are not
aware of any scientific literature regarding undergraduate
research internships in a comparable environment. This study
therefore likely represents the first attempt to evaluate student
perceptions and scientific output of such research internships.
Being able to experience clinical research in an interdisci-
plinary environment is one of the strengths that former interns
often reported in open-ended questions. Students tended to
(strongly) agree with all positive Likert statements (ranging
from 78.5% to 100% of all responses). In comparison with
academic internships, the internships at CHDR were rated to
be broader in scope. This reflects CHDR’s interdisciplinary
research in many therapeutic areas.
The commercial nature of CHDR is reflected in the survey
results by being more outcome-driven and having a stricter
planning, compared to academic internships. Several students
(>10%) thought that the commercial nature was a benefit, as it
allowed them to experience research in this setting during their
CHDR internship. The open-ended questions also revealed
some possible downsides of the commercial nature. In a com-
mercial organization, employees might be less able to spend
time supervising interns; several respondents reported that they
required additional supervision during their internship. Other
students seemed to appreciate the amount of supervision and
they reported that having responsibilities taught them to work
independently. This reflects differences between students in
the level of support they need, which has been mentioned in
the literature [13].
Because most of the clinical trials performed at CHDR are
industry-sponsored, trials can sometimes be cancelled or
delayed due circumstances outside of CHDR’s control. This
could cause uncertainty about an intern’s research project and
was listed as one of the weaknesses of the CHDR internship
programme. Overall, however, the commercial nature was not
Fig. 4. Comparison of academic and CHDR research internships. Students were asked: ‘Compare the following aspects of a CHDR internship to
an academic research internship. At CHDR that aspect is: much less/less/same/more/much more’. Results from internships with only a business/
management scope were excluded from this figure, as were respondents who were not believed to have participated in an academic research intern-
ship previously.
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considered a distraction during the internship by most (98%)
of the respondents, suggesting that the interaction of CHDR
with the pharmaceutical industry did not hinder the training of
its interns.
Pre-master students scored significantly lower on both ‘link
between internship and prior knowledge’ and ‘Own knowl-
edge of (clinical) research’ than Master students. This might
be explained by their difference in level of education at the
time of the internship. Students that participated in longer
internships scored significantly higher on ‘own knowledge of
(clinical) research’. This suggests increased learning during
longer internships at the CHDR, although it could also be
explained by the fact that pre-master students generally partici-
pated in shorter internships than Master students (who have
had more prior education). In future studies, obtaining a self-
assessment both before and after the internship would help to
discriminate between these two explanations. Together, these
data suggest that pre-master students and students participating
in short internships might benefit from additional guidance
during their internship. This will ensure that interns have a
sufficient knowledge level for an effective internship.
For many of the students, their internship at CHDR was
their first hands-on encounter with clinical research. This led
to involvement in the writing of manuscripts for 32% of the
interns. This is higher than the percentage of Dutch medical
students that published during the final three years of their
study (14.5%), although it should be mentioned that our litera-
ture search also included work published after graduation [14].
Publication rates of medical students reported in other litera-
ture range from 8 to 85%. While the publication rate of
CHDR interns is reasonable, we aim to investigate whether
there is room for improvement, as publication of results
enhances the acquisition of research skills by the students
[8,15]. This is especially true for medical students, as research
has a less prominent role in their curriculum compared to bio-
pharmaceutical and biomedical students; medical students are
more likely to pursue an academic career if they have experi-
enced research during their education [16,17]. Furthermore,
several students submitted abstracts of their research projects
to poster sessions at (inter)national meetings, but we did not
quantify this scientific output. This can be a relevant experi-
ence for students, as it trains their ability to communicate their
findings to a broader audience [15].
The response rate to the survey was 61%. Therefore, response
bias cannot be excluded, as it is possible that response rates
depend on a student’s attitude towards (their internship at)
CHDR. The results on the comparison between a CHDR and a
previous academic internship might be affected by some level of
selection bias, as both the students’ decision to apply to the
programme and their chance of acceptance can be considered
non-random. The results of this study cannot therefore be
directly extrapolated to the general (bio)medical student
population.
Another limitation is that we did not gather detailed infor-
mation about the previous internships performed by the stu-
dents. This makes the interpretation of the questions regarding
the context comparison more difficult, as the point of
reference is unclear. In future research, it would be better to
compare student perceptions of a cohort of CHDR interns with
those of a comparable cohort of interns at an academic
research group. Such a study might also assess outcome that
does not rely on student self-report, such as the grade
rewarded for the internship or for the final report.
The use of the Likert statements in this study might have
introduced bias due to acquiescence, the tendency to provide
confirmatory answers regardless of the statement [18]. While
this could have contributed to higher level of agreements to the
statements in fig. 3, it is important to note that 98% of the
respondents disagreed with the statement regarding the distrac-
tion caused by the commercial setting. Finally, the unidimen-
sional Likert items used in this questionnaire provide little
information on the factors that underlie these answers. There-
fore, we obtained such information with the open questions
regarding the strengths and weaknesses of the CHDR internship
programme. Future research should consider a more in-depth
exploration of factors that contribute to the student’s perception.
Conclusion
In general, student satisfaction was high, and many aspects were
reported similar to academic research electives such as focus on
research methodology and strictness. However, we identified
some differences, that is a broader scope and stricter planning at
CHDR electives. Importantly, by engaging in a clinical research
project, important research skills and attributes are acquired,
such as: critical appraisal, an enquiring mind, ability to work in
a team and understanding of ethics involved in human subject
research [19]. Therefore, we would advocate for combining
undergraduate training with interdisciplinary clinical research in
the (bio)medical curriculum, as we believe it can have a major
contribution to the training of the (bio)medical professionals of
tomorrow. Furthermore, we stipulate involvement of young aca-
demics in clinical drug development as this is crucial for the
increasingly complex process of question-based drug develop-
ment [20]. With proper supervision and management of expecta-
tions, effective research internships are possible within the
commercial environment of a clinical research organization.
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